New wearable device aims to unfreeze Parkinson's patients in their tracks
NCT ID NCT07542743
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests the ParkinSense system, a body-worn device that detects freezing of gait in Parkinson's disease and delivers personalized cues to help patients start walking again. Sixty participants will first use the device in a lab, then at home for two weeks. The main goal is to see if the device reduces the time spent frozen.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ParkinSense System (wearable device)
- What this could lead to
- If it works, this could provide a noninvasive tool to help Parkinson's patients move more freely and reduce freezing episodes.
- What could go wrong
- This is an early-stage study with only 60 participants, and the device is tested in a controlled lab and short home use. It may not work for all patients or in real-world conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FREEZING OF GAIT SYMPTOMS IN PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Virginia
Charlottesville, Virginia, 22903, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.